Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics

Author(s): Ali Yadollahpour

Volume 20, Issue 27, 2020

Page: [2425 - 2426] Pages: 2

DOI: 10.2174/156802662027201014152538

« Previous Next »
[1]
El-Sayed, A.; Kamel, M. Advances in nanomedical applications: Diagnostic, therapeutic, immunization, and vaccine production. Environ. Sci. Pollut. Res. Int., 2020, 27(16), 19200-19213.
[2]
Bawarski, W.E.; Chidlowsky, E.; Bharali, D.J.; Mousa, S.A. Emerging nanopharmaceuticals. Nanomedicine, 2008, 4, 273-282.
[3]
Yadollahpour, A.; Rashidi, S. Magnetic nanoparticles: A review of chemical and physical characteristics important in medical applications. Orient. J. Chem., 2015, 31, 25-30.
[4]
Debbage, P. Targeted drugs and nanomedicine: Present and future. Curr. Pharm. Des., 2009, 15, 153-172.
[5]
Yadollahpour, A. Magnetic nanoparticles in medicine: A review of synthesis methods and important characteristics. Orient. J. Chem., 2015, 31, 271-277.
[6]
d’Angelo, M.; Castelli, V.; Benedetti, E.; Antonosante, A.; Catanesi, M.; Dominguez-Benot, R.; Pitari, G.; Ippoliti, R.; Cimini, A. Theranostic nanomedicine for malignant gliomas. Frontiers in Bioengineering and Biotechnology, 2019, 7.
[7]
Santos, A.C.; Pereira, I.; Pereira-Silva, M.; Ferreira, L.; Caldas, M.; Collado-González, M.; Magalhães, M.; Figueiras, A.; Ribeiro, A.J.; Veiga, F. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity. Colloids and Surfaces B: Biointerfaces, 2019, 180, 127-140.
[8]
Romberg, B.; Hennink, W.E.; Storm, G. Sheddable coatings for long-circulating nanoparticles. Pharm. Res., 2008, 25, 55-71.
[9]
Jain Singhai, N.; Ramteke, S. CNTs mediated CD44 targeting; A paradigm shift in drug delivery for breast cancer. Genes Dis., 2020, 7, 205-216.
[10]
PIRARD. B. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov. Today, 2007, 12, 640-646.
[11]
Maia, J.; Caja, S.; Strano Moraes, M.C.; Couto, N.; Costa-Silva, B. Exosome-based cell-cell communication in the tumor microenvironment. Front. Cell Dev. Biol., 2018, 6.
[12]
Meng, W.; He, C.; Hao, Y.; Wang, L.; Li, L.; Zhu, G. Prospects and challenges of extracellular vesicle-based drug delivery system: Considering cell source. Drug Deliv., 2020, 27, 585-598.

Rights & Permissions Print Cite
Article Metrics
5
© 2025 Bentham Science Publishers | Privacy Policy